Proteomics Approaches to Uncover the Repertoire of Circulating Biomarkers for Breast Cancer
dc.contributor.author | Wang, Hong | en_US |
dc.contributor.author | Hanash, Samir M. | en_US |
dc.contributor.author | Shin, Bong Kyung | en_US |
dc.date.accessioned | 2006-09-11T15:30:02Z | |
dc.date.available | 2006-09-11T15:30:02Z | |
dc.date.issued | 2002-10 | en_US |
dc.identifier.citation | Shin, Bong Kyung; Wang, Hong; Hanash, Samir; (2002). "Proteomics Approaches to Uncover the Repertoire of Circulating Biomarkers for Breast Cancer." Journal of Mammary Gland Biology and Neoplasia 7(4): 407-413. <http://hdl.handle.net/2027.42/44966> | en_US |
dc.identifier.issn | 1083-3021 | en_US |
dc.identifier.issn | 1573-7039 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/44966 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12882525&dopt=citation | en_US |
dc.description.abstract | There is substantial interest in applying proteomics to cancer biomarker discovery. Proteomics is particularly suited for profiling biological fluids and uncovering circulating markers and is currently being applied to the identification of novel biomarkers for breast cancer. Novel proteomic approaches include direct profiling of serum using mass spectrometry, application of a variety of strategies to harness immunity for cancer diagnosis, protein tagging to capture subproteomes rich in diagnostic markers, the use of protein microarrays, and the use of multidimensional liquid protein separation technologies for comprehensive profiling of serum and other biological fluids. It is likely that the application of a wide range of proteomics tools to breast cancer will yield a panel of markers that have utility for breast cancer diagnosis. | en_US |
dc.format.extent | 777694 bytes | |
dc.format.extent | 3115 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Kluwer Academic Publishers-Plenum Publishers; Plenum Publishing Corporation ; Springer Science+Business Media | en_US |
dc.subject.other | Cancer Biomarker | en_US |
dc.subject.other | Medicine & Public Health | en_US |
dc.subject.other | Cancer Research | en_US |
dc.subject.other | Oncology | en_US |
dc.subject.other | Proteomics | en_US |
dc.subject.other | Breast Cancer | en_US |
dc.title | Proteomics Approaches to Uncover the Repertoire of Circulating Biomarkers for Breast Cancer | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationumcampus | Ann Arbor | en_US |
dc.identifier.pmid | 12882525 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/44966/1/10911_2004_Article_465907.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1023/A:1024038132381 | en_US |
dc.identifier.source | Journal of Mammary Gland Biology and Neoplasia | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.